Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-01-04

Clinical Trial Update: Treatment of Psoriasis With Parathyroid Hormone [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated parathyroid hormone as a treatment for plaque psoriasis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Parathyroid hormone (Parathyroid hormone)

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Plaque Psoriasis | Phase 1, Phase 2 | Status: COMPLETED